Business method patents have a checkered history. They were once very much in vogue—numerous such patents issued, and many of them were litigated. Then, about two years ago, Congress enacted a special ...

Get your news from a source that’s not owned and controlled by oligarchs. Sign up for the free Mother Jones Daily. On Monday, the Supreme Court affirmed a lower court ruling that struck down Bernard ...

To us, there's something oddly comforting when the Supreme Court justices all appear on the same page in a case; when Justice Scalia's comments echo Justice Breyer's, which, in turn, echo Chief ...

Maybe you are of a sufficient vintage to remember the game show Let's Make a Deal. But have you ever thought about the similarities between that show and the U.S. patent system? In the game show, ...

Following the Federal Circuit's decision in In re Bilski (Fed Cir 2008), when a method claim is not tied to a particular machine or apparatus and does not transform a particular article into a ...

Business method patents have been a contentious issue, with some saying that they're necessary for software innovation and others claiming that they prevent innovation. The Bilski case, which will be ...

A U.S. appeals court has rejected patenting a way to smooth energy costs in a closely watched decision that could narrow the scope of "business method" patents. The case turned on whether an inventor ...

At long last, business-method patents will have their moment in the spotlight. The Supreme Court on Monday will take up the issue, holding arguments in the In Re Bilski case, which has been on our ...

On April 16, 2026, the U.S. Court of Appeals for the Federal Circuit (the court) issued a precedential decision in Teva Pharmaceuticals ...

“An APOA of 17% implies that, on average, an applicant will have to respond to five rejections before getting an allowance. Nonetheless, it is now at least a realistic possibility to get a business ...

Molecular biomarkers, such as variations in genetic sequences, protein levels, or combinations of specific biochemical changes, are increasingly important to the emergence of personalized medicine.

Since 1998 business methods have been patentable in the United States. This is thanks to the decision of the United States Court of Appeals in State Street Bank & Trust Co. v. Signature Financial ...